がん/腫瘍プロファイリングの世界市場：市場規模・シェア・動向、業界分析 (がんの種類別・技術別・手法別・用途別・地域別)、将来予測 (2025年～2034年)

Polaris Market Research社の最新調査によると、世界のがん/腫瘍プロファイリングの市場規模は2034年までに353億6,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

がん/腫瘍プロファイリング市場の拡大は、世界のがんの有病率の増加と個別化医療に対する需要の高まりが原動力となっています。主な促進要因には、早期発見、より良い診断、より的を絞った治療を可能にする次世代シーケンシング (NGS) やリキッドバイオプシーなどのゲノム技術の進歩が含まれます。がん/腫瘍プロファイリングの市場機会は新興市場に存在し、そこでは医療へのアクセスや認知度の向上ががんプロファイリング技術の採用を後押ししています。

データ解析のための人工知能 (AI) の統合や非侵襲的診断手法への注目の高まりといった動向が市場を形成しています。バイオマーカー探索における継続的な技術革新と精密診断に対する規制当局の支援により、個別化されたより効果的な治療戦略を通じて患者の転帰を改善することに重点が置かれるようになり、市場は継続的に拡大する見通しです。

がん/腫瘍プロファイリング市場：分析概要

乳がんセグメントは、その高い有病率と個別化治療およびゲノムプロファイリングに対する需要の高まりにより、がん/腫瘍プロファイリング市場で最大のシェアを占めています。しかし、肺がんセグメントは、早期発見と標的治療のためのリキッドバイオプシーと先進ゲノムプロファイリングの利用の増加により、最も高い成長を記録しています。

技術別では、次世代シーケンサー (NGS) 分野が市場を独占しており、腫瘍の遺伝子プロファイルに関する包括的な洞察を提供し、精密腫瘍学を推進しています。ポリメラーゼ連鎖反応 (PCR) 分野は、その費用対効果と早期がん発見のためのリキッドバイオプシーへの応用に後押しされ、最も急速に成長している技術分野です。

手法別に基づくと、ゲノミクス分野は、個別化医療に不可欠な変異、遺伝子発現、腫瘍の不均一性に関する詳細な分子データを提供する能力により、がん/腫瘍プロファイリング市場の収益シェアをリードしています。エピジェネティクス分野は、がんの進行や治療への反応を促進する分子メカニズムの解明における役割により、最も高い成長を遂げています。

用途別では、個別化医療分野が市場を独占しています。治療方針の決定や患者の転帰改善のために、ゲノムおよびバイオマーカーに基づく検査を採用する腫瘍医が増えているためです。バイオマーカー探索分野は、がんの早期発見や進行のモニタリングのために、より精密で新しいバイオマーカーが同定されつつあり、急速に成長しています。

北米が最大の市場シェアを占めており、その背景には先進的な医療インフラと精密腫瘍学への強い関心があります。アジア太平洋地域は、医療へのアクセスの増加、がん罹患率の上昇、がんプロファイリング技術の採用拡大により、最も急速に成長している市場です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 がん/腫瘍プロファイリング市場の洞察

• 市場スナップショット
• がん/腫瘍プロファイリングの市場力学
  • 促進要因と機会
    • 診断における液体生検の統合
    • 次世代シーケンシング (NGS) の役割の拡大
  • 抑制要因と課題
    • プロファイリング技術の高コスト
• PESTLE分析
• 世界のがん/腫瘍プロファイリング市場の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のがん/腫瘍プロファイリング市場：がんの種類別

• 主な分析結果
• イントロダクション
• 乳がん
• 肺がん
• 大腸がん
• 前立腺がん
• メラノーマがん
• その他

第6章 世界のがん/腫瘍プロファイリング市場：技術別

• 主な分析結果
• イントロダクション
• 次世代シーケンシング (NGS)
• ポリメラーゼ連鎖反応 (PCR)
• 免疫組織化学 (IHC)
• インサイチューハイブリダイゼーション (ISH)
• マイクロアレイ
• その他

第7章 世界のがん/腫瘍プロファイリング市場：手法別

• 主な分析結果
• イントロダクション
• ゲノミクス
• プロテオミクス
• エピジェネティクス
• メタボロミクス

第8章 世界のがん/腫瘍プロファイリング市場：用途別

• 主な分析結果
• イントロダクション
• 個別化医療
• 診断
• バイオマーカー発見
• 予測
• その他

第9章 世界のがん/腫瘍プロファイリング市場：地域別

• 主な分析結果
• イントロダクション
  • 世界のがん/腫瘍プロファイリング市場の評価：地域別 (2020～2034年)
• 北米
  • 北米：がんの種類別 (2020～2034年)
  • 北米：技術別 (2020～2034年)
  • 北米：手法別 (2020～2034年)
  • 北米：用途別 (2020～2034年)
  • 米国
  • カナダ
• 欧州
  • 欧州：がんの種類別 (2020～2034年)
  • 欧州：技術別 (2020～2034年)
  • 欧州：手法別 (2020～2034年)
  • 欧州：用途別 (2020～2034年)
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：がんの種類別 (2020～2034年)
  • アジア太平洋：技術別 (2020～2034年)
  • アジア太平洋：手法別 (2020～2034年)
  • アジア太平洋：用途別 (2020～2034年)
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：がんの種類別 (2020～2034年)
  • 中東・アフリカ：技術別 (2020～2034年)
  • 中東・アフリカ：手法別 (2020～2034年)
  • 中東・アフリカ：用途別 (2020～2034年)
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：がんの種類別 (2020～2034年)
  • ラテンアメリカ：技術別 (2020～2034年)
  • ラテンアメリカ：手法別 (2020～2034年)
  • ラテンアメリカ：用途別 (2020～2034年)
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 事業拡大・企業買収の分析
  • 事業拡大
  • 企業買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Illumina
• Thermo Fisher Scientific
• Qiagen
• F. Hoffmann-La Roche
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Foundation Medicine (a Roche subsidiary)
• Guardant Health
• NeoGenomics Laboratories
• Pacific Biosciences
• Personalis
• GRAIL (a subsidiary of Illumina)
• Invitae
• Genomic Health (a subsidiary of Exact Sciences)

List of Tables:

• Table 1 Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 2 Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 3 Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 4 Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 5 North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 6 North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 7 North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 8 North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 9 US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 10 US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 11 US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 12 US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 13 Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 14 Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 15 Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 16 Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 17 Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 18 Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 19 Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 20 Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 21 UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 22 UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 23 UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 24 UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 25 France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 26 France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 27 France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 28 France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 29 Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 30 Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 31 Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 32 Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 33 Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 34 Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 35 Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 36 Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 37 Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 38 Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 39 Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 40 Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 41 Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 42 Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 43 Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 44 Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 45 Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 46 Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 47 Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 48 Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 49 Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 50 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 51 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 52 Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 53 Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 54 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 55 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 56 Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 57 China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 58 China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 59 China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 60 China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 61 India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 62 India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 63 India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 64 India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 65 Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 66 Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 67 Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 68 Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 69 Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 70 Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 71 Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 72 Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 73 Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 74 Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 75 Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 76 Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 77 South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 78 South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 79 South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 80 South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 81 Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 82 Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 83 Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 84 Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 85 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 86 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 87 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 88 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 89 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 90 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 91 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 92 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 93 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 94 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 95 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 96 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 97 UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 98 UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 99 UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 100 UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 101 Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 102 Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 103 Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 104 Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 105 South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 106 South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 107 South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 108 South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 109 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 110 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 111 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 112 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 113 Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 114 Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 115 Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 116 Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 117 Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 118 Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 119 Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 120 Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 121 Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 122 Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 123 Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 124 Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 125 Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 126 Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 127 Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 128 Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• Table 129 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• Table 130 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• Table 131 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• Table 132 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

List of Figures:

• Figure 1. Global Cancer or Tumour Profiling Market, 2020-2034 (USD billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Cancer Type
• Figure 7. Global Cancer or Tumour Profiling Market, by Cancer Type, 2024 & 2034 (USD billion)
• Figure 8. Market by Technology
• Figure 9. Global Cancer or Tumour Profiling Market, by Technology, 2024 & 2034 (USD billion)
• Figure 10. Market by Technique
• Figure 11. Global Cancer or Tumour Profiling Market, by Technique, 2024 & 2034 (USD billion)
• Figure 12. Market by Application
• Figure 13. Global Cancer or Tumour Profiling Market, by Application, 2024 & 2034 (USD billion)
• Figure 14. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
• Figure 15. Strategic Analysis - Global Cancer or Tumour Profiling Market

The global cancer or tumor profiling market size is expected to reach USD 35.36 billion by 2034, according to a new study by Polaris Market Research. The report "Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology, Technique, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer or tumor profiling market expansion is driven by the increasing prevalence of cancer worldwide and the growing demand for personalized medicine. Key drivers include advancements in genomic technologies such as next-generation sequencing (NGS) and liquid biopsy, which enable early detection, better diagnosis, and more targeted treatments. Cancer or tumor profiling market opportunities exist in emerging markets, where rising healthcare access and awareness are boosting the adoption of cancer profiling technologies.

Trends such as the integration of artificial intelligence (AI) for data analysis and the growing focus on noninvasive diagnostic techniques are shaping the market. With ongoing innovations in biomarker discovery and regulatory support for precision diagnostics, the market is poised for continued expansion, with a heightened emphasis on improving patient outcomes through personalized and more effective treatment strategies.

Cancer or Tumor Profiling Market Report Highlights

The breast cancer segment, by cancer type, holds the largest cancer or tumor profiling market share due to its high prevalence and the growing demand for personalized treatments and genomic profiling. However, the lung cancer segment is registering the highest growth due to the increasing use of liquid biopsy and advanced genomic profiling for early detection and targeted therapies.

By technology, the next-generation sequencing (NGS) segment dominates the market, offering comprehensive insights into tumor genetic profiles and driving precision oncology. The polymerase chain reaction (PCR) segment is the fastest-growing technology segment, fueled by its cost-effectiveness and application in liquid biopsy for early cancer detection.

The genomics segment, based on technique, leads the cancer or tumor profiling market revenue share due to its ability to provide in-depth molecular data on mutations, gene expressions, and tumor heterogeneity, which are critical for personalized medicine. The epigenetics segment is experiencing the highest growth, driven by its role in uncovering molecular mechanisms that drive cancer progression and response to treatment.

In terms of application, the personalized medicine segment dominates the market, as more oncologists adopt genomic and biomarker-based testing to guide treatment decisions and improve patient outcomes. The biomarker discovery segment is growing rapidly as new and more precise biomarkers are being identified for early detection and monitoring of cancer progression.

North America holds the largest market share, supported by its advanced healthcare infrastructure and strong focus on precision oncology. Asia Pacific is the fastest-growing market, driven by increasing healthcare access, rising cancer rates, and expanding adoption of cancer profiling technologies.

Polaris Market Research has segmented the cancer or tumor profiling market report on the basis of cancer type, technology, technique, application, and region:

By Cancer Type Outlook (Revenue - USD Billion, 2020-2034)

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In-Situ Hybridization (ISH)
• Microarray
• Others

By Technique Outlook (Revenue - USD Billion, 2020-2034)

• Genomics
• Proteomics
• Epigenetics
• Metabolomics

By Application Outlook (Revenue - USD Billion, 2020-2034)

• Personalized Medicine
• Diagnostics
• Biomarker Discovery
• Prognostics
• Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Cancer or Tumour Profiling Market Insights

• 4.1. Global Cancer or Tumour Profiling Market - Market Snapshot
• 4.2. Global Cancer or Tumour Profiling Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Integration of Liquid Biopsy in Diagnostics
    • 4.2.1.2. Growing Role of Next-Generation Sequencing (NGS)
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Cost of Profiling Technologies
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Global Cancer or Tumour Profiling Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Cancer or Tumour Profiling Market, by Cancer Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
• 5.3. Breast Cancer
  • 5.3.1. Global Cancer or Tumour Profiling Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
• 5.4. Lung Cancer
  • 5.4.1. Global Cancer or Tumour Profiling Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
• 5.5. Colorectal Cancer
  • 5.5.1. Global Cancer or Tumour Profiling Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
• 5.6. Prostate Cancer
  • 5.6.1. Global Cancer or Tumour Profiling Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
• 5.7. Melanoma Cancer
  • 5.7.1. Global Cancer or Tumour Profiling Market, by Melanoma Cancer, by Region, 2020-2034 (USD Billion)
• 5.8. Others
  • 5.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Cancer or Tumour Profiling Market, by Technology

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
• 6.3. Next-Generation Sequencing (NGS)
  • 6.3.1. Global Cancer or Tumour Profiling Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
• 6.4. Polymerase Chain Reaction (PCR)
  • 6.4.1. Global Cancer or Tumour Profiling Market, by Bakery & Confectionary, by Region, 2020-2034 (USD Billion)
• 6.5. Immunohistochemistry (IHC)
  • 6.5.1. Global Cancer or Tumour Profiling Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Billion)
• 6.6. In-Situ Hybridization (ISH)
  • 6.6.1. Global Cancer or Tumour Profiling Market, by In-Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
• 6.7. Microarray
  • 6.7.1. Global Cancer or Tumour Profiling Market, by Microarray, by Region, 2020-2034 (USD Billion)
• 6.8. Others
  • 6.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cancer or Tumour Profiling Market, by Technique

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
• 7.3. Genomics
  • 7.3.1. Global Cancer or Tumour Profiling Market, by Genomics, by Region, 2020-2034 (USD Billion)
• 7.4. Proteomics
  • 7.4.1. Global Cancer or Tumour Profiling Market, by Proteomics, by Region, 2020-2034 (USD Billion)
• 7.5. Epigenetics
  • 7.5.1. Global Cancer or Tumour Profiling Market, by Epigenetics, by Region, 2020-2034 (USD Billion)
• 7.6. Metabolomics
  • 7.6.1. Global Cancer or Tumour Profiling Market, by Metabolomics, by Region, 2020-2034 (USD Billion)

8. Global Cancer or Tumour Profiling Market, by Application

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• 8.3. Personalized Medicine
  • 8.3.1. Global Cancer or Tumour Profiling Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
• 8.4. Diagnostics
  • 8.4.1. Global Cancer or Tumour Profiling Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
• 8.5. Biomarker Discovery
  • 8.5.1. Global Cancer or Tumour Profiling Market, by Biomarker Discovery, by Region, 2020-2034 (USD Billion)
• 8.6. Prognostics
  • 8.6.1. Global Cancer or Tumour Profiling Market, by Prognostics, by Region, 2020-2034 (USD Billion)
• 8.7. Others
  • 8.7.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cancer or Tumour Profiling Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
• 9.3. Global Cancer or Tumour Profiling Market - North America
  • 9.3.1. North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 9.3.2. North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 9.3.3. North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 9.3.4. North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.3.5. Global Cancer or Tumour Profiling Market - US
    • 9.3.5.1. US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.3.5.2. US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.3.5.3. US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.3.5.4. US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.3.6. Global Cancer or Tumour Profiling Market - Canada
    • 9.3.6.1. Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.3.6.2. Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.3.6.3. Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.3.6.4. Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• 9.4. Global Cancer or Tumour Profiling Market - Europe
  • 9.4.1. Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 9.4.2. Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 9.4.3. Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 9.4.4. Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.5. Global Cancer or Tumour Profiling Market - UK
    • 9.4.5.1. UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.5.2. UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.5.3. UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.5.4. UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.6. Global Cancer or Tumour Profiling Market - France
    • 9.4.6.1. France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.6.2. France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.6.3. France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.6.4. France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.7. Global Cancer or Tumour Profiling Market - Germany
    • 9.4.7.1. Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.7.2. Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.7.3. Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.7.4. Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.8. Global Cancer or Tumour Profiling Market - Italy
    • 9.4.8.1. Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.8.2. Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.8.3. Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.8.4. Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.9. Global Cancer or Tumour Profiling Market - Spain
    • 9.4.9.1. Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.9.2. Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.9.3. Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.9.4. Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.10. Global Cancer or Tumour Profiling Market - Netherlands
    • 9.4.10.1. Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.10.2. Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.10.3. Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.10.4. Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.11. Global Cancer or Tumour Profiling Market - Russia
    • 9.4.11.1. Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.11.2. Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.11.3. Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.11.4. Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4.12. Global Cancer or Tumour Profiling Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.12.2. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.12.3. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.12.4. Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• 9.5. Global Cancer or Tumour Profiling Market - Asia Pacific
  • 9.5.1. Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 9.5.2. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 9.5.3. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 9.5.4. Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.5. Global Cancer or Tumour Profiling Market - China
    • 9.5.5.1. China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.5.2. China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.5.3. China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.5.4. China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.6. Global Cancer or Tumour Profiling Market - India
    • 9.5.6.1. India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.6.2. India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.6.3. India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.6.4. India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.7. Global Cancer or Tumour Profiling Market - Malaysia
    • 9.5.7.1. Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.7.2. Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.7.3. Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.7.4. Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.8. Global Cancer or Tumour Profiling Market - Japan
    • 9.5.8.1. Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.8.2. Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.8.3. Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.8.4. Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.9. Global Cancer or Tumour Profiling Market - Indonesia
    • 9.5.9.1. Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.9.2. Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.9.3. Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.9.4. Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.10. Global Cancer or Tumour Profiling Market - South Korea
    • 9.5.10.1. South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.10.2. South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.10.3. South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.10.4. South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.11. Global Cancer or Tumour Profiling Market - Australia
    • 9.5.11.1. Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.11.2. Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.11.3. Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.11.4. Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5.12. Global Cancer or Tumour Profiling Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.12.2. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.12.3. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.12.4. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• 9.6. Global Cancer or Tumour Profiling Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 9.6.2. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 9.6.3. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 9.6.4. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6.5. Global Cancer or Tumour Profiling Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.5.2. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.5.3. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.5.4. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6.6. Global Cancer or Tumour Profiling Market - UAE
    • 9.6.6.1. UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.6.2. UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.6.3. UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.6.4. UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6.7. Global Cancer or Tumour Profiling Market - Israel
    • 9.6.7.1. Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.7.2. Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.7.3. Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.7.4. Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6.8. Global Cancer or Tumour Profiling Market - South Africa
    • 9.6.8.1. South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.8.2. South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.8.3. South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.8.4. South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6.9. Global Cancer or Tumour Profiling Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.9.2. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.9.3. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.9.4. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
• 9.7. Global Cancer or Tumour Profiling Market - Latin America
  • 9.7.1. Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 9.7.2. Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 9.7.3. Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 9.7.4. Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7.5. Global Cancer or Tumour Profiling Market - Mexico
    • 9.7.5.1. Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.5.2. Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.5.3. Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.5.4. Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7.6. Global Cancer or Tumour Profiling Market - Brazil
    • 9.7.6.1. Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.6.2. Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.6.3. Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.6.4. Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7.7. Global Cancer or Tumour Profiling Market - Argentina
    • 9.7.7.1. Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.7.2. Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.7.3. Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.7.4. Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7.8. Global Cancer or Tumour Profiling Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.8.2. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.8.3. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.8.4. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Illumina
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Thermo Fisher Scientific
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Qiagen
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. F. Hoffmann-La Roche
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Agilent Technologies
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Bio-Rad Laboratories
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. PerkinElmer
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Foundation Medicine (a Roche subsidiary)
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Guardant Health
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. NeoGenomics Laboratories
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Pacific Biosciences
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Personalis
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. GRAIL (a subsidiary of Illumina)
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Invitae
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Genomic Health (a subsidiary of Exact Sciences)
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development